Abstract
Abnormalities of renal excretion of urate may result in either hyperuricemia or hypouricemia, or an increase or reduction in the elimination of uric acid by the renal tract. These four abnormalities may also be found in various combinations, the most common being hyperuricemia and reduced renal excretion of urate. However, abnormalities of plasma urate may occur without apparent abnormality of renal excretion, and abnormalities of excretion may be present with normal serum urate concentrations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acheson, R.M., Florey, C.V.: Body weight, ABO blood-groups, and altitude of domicile as determinants of serum-uric-acid in military recruits in four countries. Lancet 1969, II, 391–394
Akaoka, I., Nishizawa, T., Yano, E., Takeuchi, A., Nishida, Y.: Familial hypouricaemia due to renal tubular defect of urate transport. Ann. clin. Res. 7, 318–324 (1975)
Alepa, F.P., Howell, R.R., Klinenberg, J.R., Seegmiller, J.E.: Relationships between glycogen storage disease and tophaceous gout. Amer. J. Med. 42, 58–66 (1967)
Amidi, M.: Type IV hyperlipoproteinaemia in a consanguineous family. Circulation 45, 988–990 (1972)
Appleton, M.D., Haab, W., Burti, U., Orsulak, P.J.: Plasma urate levels in mongolism. Amer. J. ment. Defic. 74, 196–199 (1969)
Aronow, W.S., Vangrow, J.S., Nelson, W.H., Pagano, J., Papageorge’s, N.P., Khursheed, M., Harding, P.R., Khemka, M.: Halofenate: an effective hypolipemia- and hypouricemia-induc-ing drug. Curr. ther. Res. 15, 902–906 (1973)
Ayvazian, J.H., Ayvazian, L.F.: A study of the hyperuricaemia induced by hydrochlorothiazide and acetazolamide separately and in combination. J. clin. Invest. 40, 1961–1966 (1961)
Ball, G.V., Sorensen, L.B.: Pathogenesis of hyperuricemia in saturnine gout. New Engl. J. Med. 280, 1199–1202 (1969)
Ballantyne, D., Strevens, E.A., Lawrie, T.D.V.: Relationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular disease. Clin. chim. Acta 70, 323–328 (1976)
Barlow, K.A.: Hyperlipidemia in primary gout. Metabolism 17, 289–299 (1968)
Benedek, T.G.: Correlations of serum uric acid and lipid concentrations in normal, gouty and atherosclerotic men. Ann. intern. Med. 66, 851–861 (1967)
Bengtsson, C., Johnsson, G., Sannerstedt, R., Werko, L.: Effect of different doses of chlorthalidone on blood pressure, serum potassium and serum urate. Brit. med. J. 1975, I, 197–199
Bennett, J.S., Bond, J., Singer, I., Gottlieb, A.J.: Hypouricemia in Hodgkin’s disease. Ann. intern. Med. 76, 751–756 (1972)
Berger, L., Yü, T.F.: Renal function in gout. IV. An analysis of 524 gouty subjects including long term follow-up studies. Amer. J. Med. 59, 605–613 (1975)
Berger, L., Yü, T.F., Atsmon, A., Kupper, S., Gutman, A.B.: Effect of reducing renal arterial blood pressure by balloon catheter on urate excretion in the dog. Proc. Soc. exp. Biol. (N.Y.) 115, 58–61 (1964)
Bishop, C., Pfaff, W.: Immediate uricosuric effect of probenecid in normal humans. Proc. Soc. exp. Biol. (N.Y.) 87, 346–348 (1955)
Bishop, C., Zimdahl, W.T., Talbott, J.H.: Uric acid in two patients with Wilson’s disease (hepatolenticular degeneration). Proc. Soc. exp. Biol. (N.Y.) 8, 440 (1954)
Blacket, R.B., Leelarthaepin, B., Palmer, A.J., Woodhill, J.M.: Coronary heart disease in young men: a study of 70 patients with a critical review of etiological factors. Aust. N.Z. J. Med. 3, 39–62 (1973)
Bluestone, R., Lewis, B., Mervart, I.: Hyperlipoproteinaemia in gout. Ann. rheum. Dis. 30, 134 – 137 (1971)
Bonsnes, R.W., Dana, E.S.: On the increased uric acid clearance following the intravenous infusion of hypertonic glucose solutions. J. clin. Invest. 25, 386–388 (1946)
Bonsnes, R.W., Dill, L.V., Dana, E.S.: The effect of Diodrast on the normal uric acid clearance. J. clin. Invest. 23, 776 (1944)
Bosco, J.S., Greenleaf, J.E., Kaye, R.L., Averkin, E.G.: Reduction of serum uric acid in young men during physical training. Amer. J. Cardiol. 25, 46–52 (1970)
Bourke, E., Ledingham, J.G.G., Stokes, G.S.: Effects of intravenous ethacrynic acid on the renal handling of citrate and urate in man. Clin. Sci. 31, 231–246 (1966)
Bowering, J., Calloway, D.H., Margen, S., Kaufmann, N.A.: Dietary protein level and uric acid metabolism in normal man. J. Nutr. 100, 249–261 (1970)
Boyle, J.A., McKiddie, M., Buchanan, K.D., Jasani, M.K., Gray, H.W., Jackson, I.M.D., Buchanan, W.W.: Diabetes mellitus and gout. Blood sugar and plasma insulin responses to oral glucose in normal weight, overweight and gouty patients. Ann. rheum. Dis. 28 (Suppl. 1), 374–378 (1969)
Breckenridge, A.: Hypertension and hyperuricaemia. Lancet 1966, I, 15–18
Brøchner-Mortensen, K.: Uric acid in blood and urine. Acta med. scand. [Suppl. 1] 84 (1937)
Brodan, V., Brodanov, A., Kuhn, E., Filip, J., Pechar, J.: Ammonia and uric acid formation after rapid intravenous fructose administration to healthy subjects and patients with compensated cirrhosis of the liver. Nutr. Metab. 19, 233–241 (1975)
Bulpitt, C.J.: Blood urea changes in hypertensive patients according to therapy given, blood pressure control, and serum potassium levels. Brit. Heart J. 36, 383–386 (1974)
Bulpitt, C.J.: Serum uric acid in hypertensive patients. Br. Heart J. 37, 1210–1215 (1975)
Burch, R.E., Kurke, N.: The effect of lactate infusion on serum uric acid. Proc. Soc. exp. Biol. (N.Y.) 127, 17–20 (1968)
Burns, J.J., Yü, T.F., Berger, L., Gutman, A.B.: Zoxazolamine-physiological disposition and uricosuric properties. Amer. J. Med. 25, 401–408 (1958)
Burns, J.J., Yü, T.F., Ritterband, A., Perei, J.M., Gutman, A.B., Brodie, B.B.: A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G25671. J. Pharmacol. exp. Ther. 119, 418–426 (1957)
Cameron, J.S.: Uric acid and the kidney. Proc. roy. Soc. Med. 66, 900–902 (1973)
Camus, J.P., Ghata, J., Guillien, P.: Etude de quelques fractions lipidiques du plasma dans la goutte. J. med. liban. 3, 261–269 (1969)
Cannon, P.J., Symchych, P.S., Martini, F.E., de: The distribution of urate in human and primate kidney. Proc. Soc. exp. Biol. (N.Y.) 129, 278–284 (1968)
Cannon, P.J., Svahn, D.S., Martini, F.E., de: The influence of hypertonic saline infusions upon the fractional reabsorption of urate and other ions in normal and hypertensive man. Circulation 41, 97–108 (1970)
Chait, A., Mancini, M., February, A.W., Lewis, B.: Clinical and metabolic study of alcoholic hy-perlipidaemia. Lancet 1972, II, 62–64
Chesley, L.C., Williams, L.O.: Renal glomerular and tubular function in relation to hyperuricemia of pre-eclampsia and eclampsia. Amer. J. Obstet. Gynecol. 50, 367–375 (1945)
Clarkson, B.A.: Uric acid related to uraemic symptoms. Proceedings of the European Dialysis and Transplant Association, pp. 3–7. Amsterdam: Excerpta Medica 1966
Coburn, S.P., Seidenberg, M., Mertz, E.T.: Clearance of uric acid, urea and creatinine in Down’s syndrome. J. appl. Physiol. 24, 579–580 (1967)
Coburn, S.P., Sirlin, E.M., Mertz, E.T.: Metabolism of N15 labelled uric acid in Down’s syndrome. Metabolism 17, 560–562 (1968)
Coe, F.L., Kavalach, A.G.: Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. New Engl. J. Med. 291, 1344–1350 (1974)
Cohen, R.D., Woods, H.F.: Clinical and biochemical aspects of lactic acidosis. Oxford-London: Blackwell 1976
Connon, A.F., Wadsworth, R.J.: An evaluation of serum uric acid estimations in toxemia of pregnancy. Aust. N.Z.J. Obstet. Gynaec. 8, 197–201 (1968)
Coronary Drug Project Research Group: Serum uric acid: Its association with other risk factors and with mortality in coronary heart disease. J. chron. Dis. 29, 557–569 (1976)
Cowdrey, S.C.: Hyperuricemia in infectious mononucleosis. J. Amer. med. Ass. 196, 319–321 (1966)
Cullen, J.H., Levine, M., Fiore, J.M.: Studies of hyperuricaemia produced by pyrazinamide. Amer. J. Med. 32, 587–596 (1957)
Danovitch, G.M., Weinberger, J., Berlyne, G.M.: Uric acid in advanced renal failure. Clin. Sci. 43, 331–341 (1972)
Darlington, L.G., Scott, J.T.: Plasma levels in gout. Ann. rheum. Dis. 31, 487–489 (1972)
Davies, D.F., Shock, N.W.: The variability of measurement of inulin and diodrast tests of kidney function. J. clin. Invest. 29, 491–495 (1950)
Denis, G., Launay, M.P.: Carbohydrate intolerance in gout. Metabolism 18, 770–775 (1969)
Diamond, H.S., Carter, A.C., Feldman, E.B.: Abnormal regulation of carbohydrate metabolism in primary gout. Ann. rheum. Dis. 33, 554–562 (1974)
Diamond, H.S., Lazarus, R., Kaplan, D., Halberstam, D.: Effect of urine flow rate on urie acid excretion in man. Arthr. and Rheum. 15, 338–346 (1972)
Diamond, H.S., Meisel, A., Sharon, E., Holden, D., Cacatian, A.: Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia. Amer. J. Med. 59, 796–802 (1975)
Dollery, C.T., Duncan, H., Schumer, B.: Hyperuricaemia related to treatment of hypertension. Brit. med. J. 1960, II, 832–835
Dorhout Mees, E.J., Assendelft, P.B., Niewenhus, M.G.: Elevation of uric acid clearance caused by inappropriate antidiuretic hormone secretion. Acta. med. scand. 189, 69–72 (1971)
Dosman, J.A., Crawhall, J.C., Klassen, G.A.: Uric acid kinetic studies in the immediate post-myocardial infarction period. Metabolism 24, 473–480 (1975)
Drenick, E.J., Swendseid, M.E., Blahd, W.H., Tuttle, S.G.: Prolonged starvation as a treatment for severe obesity. J. Amer. med. Ass. 187, 100–105 (1964)
Duarte, C.G., Bland, J.H.: Calcium, phosphorus and uric acid clearances after intravenous administration of chlorothiazide. Metabolism 14, 211–219 (1965)
Dubin, A., Kushner, D.S., Bronsky, D., Pascale, L.R.: Hyperuricemia in hypoparathyroidism. Metabolism 5, 703–709 (1956)
Dujovne, C.A., Azarnoff, D.L., Huffman, D.H., Pentiklainen, P., Hurwitz, A., Shoeman, D.W.: One-year trials with halofenate, Clofibrate and placebo. Clin. Pharmacol. Ther. 19, 352–359 (1976)
Eisen, A.Z., Seegmiller, J.E.: Uric acid metabolism in psoriasis. J. clin. Invest. 40, 1486–1494 (1961)
Emmerson, B.T.: Chronic lead nephropathy: the diagnostic use of calcium EDTA and the association with gout. Aust. Ann. Med. 12, 310–324 (1963)
Emmerson, B.T.: The renal excretion of urate in chronic lead nephropathy. Aust. Ann. Med. 14, 295–303 (1965)
Emmerson, B.T.: Metals and the kidney. In: Black, D.A.K. (Ed.): Renal Disease, 2nd Ed., p. 575. Oxford: Blackwell 1967
Emmerson, B.T.: Alteration of urate metabolism by weight reduction. Aust. N.Z. J. Med. 3, 410 – 412(1973)
Emmerson, B.T.: Effect of oral fructose on urate production. Ann. rheum. Dis. 33, 276–280 (1974)
Emmerson, B.T., Gordon, R.B., Johnson, L.A.: Urate kinetics in hypoxanthineguanine phospho-ribosyltransferase deficiency: their significance for the understanding of gout. Quart. J. Med. 45, 49–61 (1976a)
Emmerson, B.T., Knowles, B.R.: Triglyceride concentrations in primary gout and gout of chronic lead nephropathy. Metabolism 20, 721–729 (1971)
Emmerson, B.T., Ravenscroft, P.J., Williams, G.: The effect of urine flow rate on urate clearance. Z. klin. Chem. Biochem. 14, 285–286 (1976b)
Emmerson, B.T., Row, P.G.: An evaluation of the pathogenesis of the gouty kidney. Kidney Int. 8, 65–71 (1975)
Emmerson, B.T., Thompson, L., Mitchell, K.: Dose response relationship of a uricosuric diuretic. J. clin. Chem. Biochem. 14, 286 (1976 c)
Epstein, F.H., Pigeon, G.: Experimental urate nephropathy: studies of the distribution of urate in renal tissue. Nephron 1, 144–157 (1964)
Evans, J.G., Prior, I. A.M., Harvey, H.P.B.: Relation of serum uric acid to body bulk, haemoglobin, and alcohol intake in two South Pacific Polynesian populations. Ann. rheum. Dis. 27, 319–325 (1968)
Fadel, H.E., Northrop, G., Misenhimer, H.R.: Hyperuricemia in pre-eclampsia. A reappraisal. Amer. J. Obstet. Gynec. 125, 640–647 (1976)
Fallon, H.J., Frei, E.M., III., Block, J., Seegmiller, J.E.: The uricosuria and orotic aciduria induced by 6-Azauridine. J. clin. Invest. 40, 1906–1914 (1961)
Feldman, E.B., Wallace, S.L.: Hypertriglyceridaemia in gout. Circulation 29, 508–513 (1964)
Ferris, T.F., Gorden, P.: Effect of angiotensin and norepinephrine upon urate clearance in man. Amer. J. Med. 44, 359–365 (1968)
Fine, R.N., Strauss, J., Donnell, G.N.: Hyperuricemia in glycogen-storage disease type I. Amer. J. Dis. Child. 112, 572–576 (1966)
Fox, I.H., Halperin, M.L., Goldstein, M.B., Marliss, E.B.: Renal excretion of uric acid during prolonged fasting. Metabolism 25, 551–559 (1976)
Fox, I.H., Kelley, W.N.: Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 21, 713–721 (1972)
Fredrickson, D.S., Levy, R.I.: Familial hyperlipoproteinaemia. In: Stanbury, J.B., Wyngaar-den, J.B., Fredrickson, D.S. (Eds.): The Metabolic Basis of Inherited Disease, 3rd Ed., pp. 545–614. New York: McGraw Hill 1972
Friedman, M.: The effect of glycine on the production and excretion of uric acid. J. clin. Invest. 26, 815–819 (1947)
Fulop, M., Horowitz, M., Jaffe, A.A.: Lactic acidosis in pulmonary edema due to left ventricular failure. Ann. intern. Med. 79, 180–186 (1973)
Garrick, R., Bauer, G.E., Ewan, C.E., Neale, F.C.: Serum uric acid in normal and hypertensive Australian subjects. Aust. N.Z. J. Med. 2, 351–356 (1972)
Gaut, Z.N., Pocelinko, R., Solomon, H.M., Thomas, G.B.: Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid. Metabolism 20, 1031–1035 (1971)
Gebbie, T., Prior, I.A.M.: Alcoholic hyperlipaemia. Med. J. Aust. 2, 769–772 (1967)
Gershon, S.L., Fox, I.H.: Pharmacologic effects of nicotinic acid on human purine metabolism. J. Lab. clin. Med. 84, 179–186 (1974)
Gertler, M.M., Garn, S.M., Levine, S.A.: Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann. intern. Med. 34, 1421–1431 (1951)
Gibson, H.V., Doisy, E.A.: A note on the effect of some organic acids upon the uric acid excretion of man. J. biol. Chem. 55, 605 (1923)
Gibson, T., Grahame, R.: Gout and hyperlipidaemia. Ann. rheum. Dis. 33, 298–303 (1974)
Gibson, T., Sims, H.P., Jimenez, S.A.: Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism. Ann. rheum. Dis. 35, 372–376 (1976)
Ginsberg, H., Olefsky, J., Farquhar, J.W., Reaven, G.M.: Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Ann. intern. Med. 80, 143–149 (1974)
Goldfinger, S., Klinenberg, J.R., Seegmiller, J. E.: Renal retention of uric acid induced by infusions of ß-hydroxy-butyrate and acetoacetate. New Engl. J. Med. 272, 351–355 (1965)
Gordon, R.D., Symonds, E.M., Wilmshurst, E.G., Pawsey, C.G.K.: Plasma renin activity, plasma angiotensin and plasma and urinary electrolytes in normal and toxemic pregnancy, including a prospective study. Clin. Sci. molec. Med. 45, 115–127 (1973)
Granarne, R., Scott, J.T.: Clinical survey of 354 patients with gout. Ann. rheum. Dis. 29, 461–468 (1970)
Greene, M.L., Marcus, R., Aurbach, G.D., Kazam, E.S., Seegmiller, J.E.: Hypouricemia due to isolated renal tubular defect. Amer. J. Med. 53, 361–367 (1972)
Gresham, G.E., Keller, M.D.: Hyperuricaemia and chronic renal disease. J. Chron. Dis. 23, 755 – 762(1971)
Griebsch, A., Zollner, N.: Normal werte der Plasmaharnsäure in Süddeutschland. Z. Klin. Chem. Biochem. 11, 346–356 (1973)
Gulati, O.P.: Cited in Editorial: Renal Disease and Urate Excretion. J. Ass. Phycns India 22, 349–351 (1974)
Harris-Jones, J.N.: Hyperuricaemia and essential hypercholesterolaemia. Lancet 1957, I, 857
Heinemann, H. O., Martini, F.E., de, Laragh, J.H.: The effect of chlorothiazide on renal excretion of electrolytes and free water. Amer. J. Med. 26, 853–861 (1959)
Hensley, M.J., Read, D.J.C.: Intermittent obstruction of the upper airway during sleep causing profound hypoxaemia. Aust. N.Z.J. Med. 6, 481–486 (1976)
Heuckenkamp, P.-U., Zollner, N.: Fructose-induced hyperuricaemia. Lancet 1971, I, 808–809
Hodari, A.A., Srnery, R., Bumpus, F.M.: A renin-like substance in the human placenta. Obstet. Gynec. 29, 313–317 (1967)
Hollister, L.E., Overall, J.E., Snow, H.L.: Relationship of obesity to serum triglyceride, cholesterol and uric acid and to plasma glucose levels. Amer. J. clin. Nutr. 20, 777–782 (1967)
Holmes, E.W., Kelley, W.N., Wyngaarden, J.B.: The kidney and uric acid excretion in man. Kidney Int. 2, 115–118 (1972)
Howell, R.R., Ashton, D.M., Wyngaarden, J.B.: Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid and purine abnormalities. Pediatrics 29, 553–565 (1962)
Hülsmann, W.C., Eijkenboom, W.H.M., Koster, J.F., Fernandes, J.: Glucose-6-phosphatase deficiency and hyperlipidaemia. Clin. chim. Acta 30, 775–778 (1970)
Ingbar, S.H., Kass, E.H., Burnett, C.N., Relman, A.S., Burrows, B.A., Sesson, J.H.: Effects of ACTH and cortisone on renal tubular transport of uric acid, phosphorus and electrolytes in patients with normal renal and adrenal function. J. Lab. clin. Med. 38, 533–541 (1951)
Isomaki, H., Kreus, K.-E.: Serum and urinary uric acid in respiratory acidosis. Acta med. scand. 184, 293–296 (1968)
Jackson, W.P.U., Harris, F.: Gout with hyperparathyroidism: Report of case with examination of synovial fluid. Brit. med. J. 1965, II, 211
Jakovcic, S., Sorensen, L.B.: Studies of uric acid metabolism in glycogen storage disease associated with gouty arthritis. Arthr. and Rheum. 10, 129–134 (1967)
Jensen, J., Blankenhorn, D.H., Kornerup, V.: Blood-uric-acid levels in familial hypercholes-terolaemia. Lancet 1966, I, 298–300
Johnson, R.H., Walton, J.L., Krebs, H.A., Williamson, D.H.: Metabolic fuels during and after severe exercise in athletes and non-athletes. Lancet 1969, I, 452–455
Jones, D.P., Losowsky, M.S., Davidson, C.S., Lieber, C.S.: Effects of ethanol on plasma lipids in man. J. Lab. clin. Med. 62, 675–682 (1963)
Kahn, M.F.: Goutte, obésité et plaisirs de la table. (Comparison entre 40 goutteux et 40 témoins). Nouv. Presse méd. 5, 1897–1898 (1976)
Katz, J.L., Weiner, H., Gutman, A., Yü, T.-F.: Hyperuricemia, gout, and the executive suite. J. Amer. med. Ass. 224, 1251–1257 (1973)
Kaufman, J.M.: Hyperuricemia in mongolism. New Engl. J. Med. 276, 953–956 (1967)
Kaye, J.P., Galton, D.J.: Triglyceride production rates in patients with type IV hypertriglyc-eridaemia. Lancet 1975, I, 1005–1007
Kelley, W.N., Goldfinger, S.E., Hardy, H.L.: Hyperuricemia in chronic beryllium disease. Ann. intern. Med. 70, 977–983 (1969)
Kelley, W.N., Greene, M.L., Fox, I.H., Rosenbloom, R.M., Levy, R.I., Seegmiller, J.E.: Effects of orotic acid on purine and lipoprotein metabolism in man. Metabolism 19, 1025–1053 (1970)
Kelley, W.N., Rosenbloom, F.M., Seegmiller, J.E.: The effects of azathioprine (Imuran) on purine synthesis in clinical disorders of purine metabolism. J. clin. Invest. 46, 1518–1529 (1967)
Kelley, W.N., Rosenbloom, F.M., Seegmiller, J.E., Howell, R.R.: Excessive production of uric acid in type I glycogen storage disease. J. Pediat. 72, 488–496 (1968)
Khachadurian, A.K., Arslanian, M.J.: Hypouricemia due to renal uricosuria. Ann. intern. Med. 78, 547–550 (1973)
Kinsey, D.: Gout and hyperuricaemia in hypertensive patients 15–25 years following lumbodor-sal sympathectomy. Arthr. and Rheum. 6, 778–779 (1963)
Kippen, J., Whitehouse, M.W., Klinenberg, J.R.: Pharmacology of uricosuric drugs. Ann. rheum. Dis. 33, 391–396 (1974)
Klein, W.W.: Leberfunktion bei Gicht und asymptomatischer Hyperurikämie. Z. Rheumaforsch. 30, 230–235 (1971).
Knochel, J.P., Dotin, L.N., Hamburger, R.J.: Heat stress, exercise and muscle injury: Effects on urate metabolism and renal function. Ann. intern. Med. 81, 321–328 (1974)
Krakoff, I.H., Balis, M.E.: Studies on the uricogenic effect of 2-substituted thiadiazoles in man. J. clin. Invest. 38, 907–915 (1959)
Kramer, H.J., Lu, E., Gonick, H.E.: Organic acid excretion patterns in gout. Ann. rheum. Dis. 31, 137–144 (1972)
Kreisberg, R.A., Owen, W.C., Siegal, A.M.: Ethanol-induced hyperlactic-acidemia: Inhibition of lactate utilization. J. clin. Invest. 50, 166–185 (1971)
Kuntz, D., Roques, C., Paolaggi, F., Ryckewaert, A.: Étude comparative de la triglycéridèrnie, de la lipidémie, de la glycémie et de l’index pondéral chez les hyperuricémiques et les normo-uricémiques. Path. et Biol. (Paris) 17, 399–403 (1969)
Lajtha, L.G., Vane, J.R.: Dependence of bone marrow cells on the liver for purine supply. Nature (Lond.) 182, 191–192(1958)
Lee, D.B., Drinkard, J.P., Rosen, V.J., Gonick, H.C.: The adult Fanconi syndrome. Observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine (Baltimore) 51, 107–138 (1972)
Leeper, R.D., Benua, R.S., Brener, J.L., Rawson, R.W.: Hyperuricemia in myxedema. J. clin. En-docr. 20, 1457–1466 (1960)
Lefèvre, A., Adler, H., Lieber, C.S.: Effect of ethanol on ketone metabolism. J. clin. Invest. 49, 1775–1782(1970)
Lefkovits, A.M., Herman, J.T., Irving, C.C.: Cessation of gout following portacaval shunt. J. Amer. med. Ass. 205, 213–214 (1968)
Lemieux, G., Kiss, A., Gougoux, A., Vinay, P.: Tienilic acid (Ticrynafen): a new diuretic with uricosuric properties in man and dog. J. clin. Chem. Biochem. 14, 306 (1976)
Lemieux, G., Vinay, P., Gougoux, A., Michaud, G.: Nature of the uricosuric action of benzioda-rone. Amer. J. Physiol. 224, 1440–1449 (1973)
Lieber, C.S.: The metabolism of alcohol. Sci. Amer. 234, 25–33 (1976)
Lieber, C.S., Jones, D.P., Losowsky, M.S., Davidson, C.S.: Interrelation of uric acid and ethanol metabolism in man. J. clin. Invest. 41, 1863–1870 (1962)
Losowsky, M.S., Jones, D.P., Davidson, C.S., Lieber, C.S.: Studies of alcoholic hyperlipemia and its mechanism. Amer. J. Med. 35, 794–803 (1963)
Losowsky, M.S., Kenward, D.H.: Lipid metabolism in acute and chronic renal failure. J. Lab. clin. Med. 71, 736–743 (1968)
MacLachlan, M.J., Rodnan, G.P.: Effects of food, fast, and alcohol on serum uric acid and acute attacks of gout. Amer. J. Med. 42, 38–57 (1967)
McPhaul, J.J.: Hyperuricaemia and urate excretion in chronic renal disease. Metabolism 17, 430–438 (1968)
Maenpaa, P.H., Raivio, K.O., Kekomaki, M.P.: Liver adenine nucleotides: Fructose-induced depletion and its effect on protein synthesis. Science 161, 1253–1254 (1968)
Manuel, M.A., Steele, T.H.: Changes in renal urate handling after prolonged thiazide treatment. Amer. J. Med. 57, 741–746 (1974)
Maria, F.J., de, See, H.Y.C.: Role of the placenta in pre-eclampsia. Amer. J. Obstet. Gynec. 94, 471–476 (1966)
Martinez-Maldonado, M.: Polycystic kidney disease and hyperuricemia. Ann. intern. Med. 80, 116 (1974)
Meisel, A., Diamond, H.: Effect of vasopressin on uric acid excretion: evidence for distal nephron reabsorption of urate in man. Clin. Sci. molec. Med. 51, 33–40 (1976)
Mertz, D.R.: Gicht, Diabetes Mellitus und Fettleber. Münch. med. Wschr. 5, 180–185 (1972)
Mertz, D.P., Schwoerer, P., Babucke, G.: On the classification of hyperlipoproteinaemia in primary gout. Dtsch. med. Wschr. 15, 600–604 (1972)
Michelis, M.F., Warms, P.C., Fusco, R.P., Davis, B.B.: Hypouricemia and hyperuricosuria in Laennec cirrhosis. Arch. intern. Med. 134, 681–683 (1974)
Mielants, H., Veys, E.M., Weerat, A., de: Gout and its relation to lipid metabolism. I. Serum uric acid, lipid and lipoprotein levels in gout. II. Correlation between uric acid, lipid, and lipoprotein levels in gout. Ann. rheum. Dis. 32, 501–509 (1973)
Mintz, D.H., Canary, J.J., Carreon, G., Kyle, L.H.: Hyperuricemia in hyperparathyroidism. New Engl. J. Med. 265, 112–115 (1961)
Monkus, E., Nyhan, W.L., Fogel, B.J., Yankow, S.: Concentrations of uric acid in the serum of neonatal infants and their mothers. Amer. J. Obstet. Gynec. 108, 91–97 (1970)
Morgan, J.M., Hartley, M.W., Miller, R.E.: Nephropathy in chronic lead poisoning. Arch. intern. Med. 118, 17–29 (1966)
Myers, A.R., Epstein, F.H., Dodge, H.J., Mikkelsen, W.M.: The relationship of serum uric acid to risk factors in coronary heart disease. Amer. J. Med. 45, 520–528 (1968)
Nanra, R.S.: Personal communication (1976)
Newcombe, D.S.: Ethanol metabolism and uric acid. Metabolism 21, 1193–1203 (1972)
Newcombe, D.S.: Gouty arthritis and polycystic kidney disease. Ann. intern. Med. 79, 605–606 (1973)
Nicholls, A., Scott, J.T.: Effect of weight loss on plasma and urinary levels of uric acid. Lancet 1972, II, 1223–1224
Nicholls, A., Snaith, M.L., Scott, J.T.: Effect of oestrogen therapy on plasma and urinary levels of uric acid. Brit. med. J. 1973, I, 449–451
Nichols, J., Miller, A.T., Hiatt, E. P.: Influence of muscular exercise on uric acid excretion in men. J. appl. Physiol. 3, 501–507 (1951)
Olefsky, J.M., Farquhar, J.W., Reaven, G.M.: Reappraisal of the role of insulin in hypertriglyceridemia. Amer. J. Med. 57, 551–560 (1974)
Ostberg, Y.: Renal urate deposits in chronic renal insufficiency. Acta med. scand. 183, 197–201 (1968)
Ostrander, L.D., Lamphiear, D.E., Block, W.D., Johnson, B.C., Ravenscroft, C., Epstein, F.H.: Relationship of serum lipid concentrations to alcohol consumption. Arch. intern. Med. 134, 451–456 (1974)
Pablico, R.C., Canfield, C.J., Barry, K.G.: The effects of acute total caloric starvation on uric acid metabolism in obese human subjects. Clin. Res. 13, 45 (1965)
Padova, J., Bendersky, G.: Hyperuricemia in diabetic ketoacidosis. New Engl. J. Med. 267, 530 – 534 (1962)
Padova, J., Patchefsky, A., Onesti, G., Faludi, G., Bendersky, G.: The effect of glucose loads on renal uric acid excretion in diabetic patients. Metabolism 13, 507–512 (1964)
Peenen, H. J., Van: The causes of nonazotemic hyperuricemia. Amer. J. clin. Pathol. 55, 698–700 (1971)
Pell, S., D’Alonzo, C.A.: The prevalence of chronic disease among problem drinkers. Arch. environ. Hlth. 16, 679–684 (1968)
Perheentupa, J., Raivio, K.: Fructose-induced hyperuricaemia. Lancet 1967, II, 528–531
Pollak, V.E., Nettles, J.B.: The kidney in toxemia of pregnancy. A clinical and pathological study based on renal biopsies. Medicine (Baltimore) 39, 469–526 (1960)
Postlethwaite, A.E., Kelley, W.N.: Uricosuric effect of radio contrast agents. A study in man of four commonly used preparations. Ann. intern. Med. 74, 845–852 (1971)
Postlethwaite, A.E., Kelley, W.N.: Studies on the mechanism of ethambutol-induced hyperuricemia. Arthr. and Rheum. 15, 403–409 (1972)
Postlethwaite, A.E., Ramsdell, M., Kelley, W.N.: Uricosuric effect of an anticholinergic agent in hyperuricemic subjects. Arch. intern. Med. 134, 270–275 (1974)
Praetorius, E., Kirk, J.E.: Hypouricaemia: with evidence for tubular elimination of uric acid. J. Lab. clin. Med. 35, 865–868 (1950)
Raivio, K.O., Becker, M.A., Meyer, L.J., Greene, M.L., Nuki, G., Seegmiller, J.E.: Stimulation of human purine synthesis de novo by fructose infusion. Metabolism 24, 861–869 (1975)
Ramsay, L., Levine, D., Shelton, J., Branch, R., Auty, R.: Alkalosis and urate clearance. Ann. intern. Med. 83, 903–904 (1975)
Ramsdell, C.M., Postlethwaite, A.E., Kelley, W.N.: Uricosuric effect of glyceryl guaiacolate. J. Rheumatol. 1, 114–116 (1974)
Ravenscroft, P.J., Sands, J.M., Emmerson, B.T.: Studies of the uricosuric action of the hypolipidemic drug halofenate. Clin. Pharmacol. Ther. 14, 547–551 (1973)
Redman, C.W., Beilin, L.J., Bonnar, J., Wilkinson, R.H.: Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1974, I, 1370–1373
Redman, C.W., Bonnar, J., Beilin, L.J., McNeilly, A.S.: Prolactin in hypertensive pregnancy. Brit, med. J. 1976, I, 304–306
Reese, O.G., Steele, T.H.: Renal transport of urate during diuretic-induced hypouricemia. Amer. J. Med. 60, 973–978 (1976)
Richet, G.: Some aspects of uric acid metabolism in chronic renal failure. In: Berlyne, G.M. (Ed.): Nutrition in Renal Disease. Edinburgh: Livingstone 1968
Richet, G., Albahary, C., Ardaillou, R., Sultan, C., Morel-Maroger, A.: Le rien du saturnisme chronique. Rev. franc. Étud. clin. biol. 9, 188–196 (1964)
Richet, G., Mignon, F., Ardaillou, R.: Goutte secondaire des nephropathies chroniques. Presse méd. 73, 633–638 (1965)
Rieselbach, R.E., Sorensen, L.B., Shelp, W.D., Steele, T.H.: Diminished renal urate secretion per nephron as a basis for primary gout. Ann. intern. Med. 73, 359–366 (1970)
Rondier, J., Truffert, J., Go, A., le, Brouilhet, H., Saporta, L., Gennes, J.L., de, Delbarre, F.: Goutte et hyperlipidémies (étude portant sur 50 goutteux et sur 50 sujets non gouttes). Rev. europ. Étud. clin. biol. 15, 959–968 (1970)
Rosenfeld, J.B.: Effect on long term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricaemic subjects. In: Sperling, O., De Vries, A., Wyngaarden, J.B. (Eds.): Purine Metabolism in Man. Advances in Experimental Medicine and Biology, Vol. XLIB, pp. 581–596. New York: Plenum 1974
Sahebjami, H., Scalettar, R.: Effects of fructose infusion on lactate and uric acid metabolism. Lancet 1971, I, 366–369
Saker, B.M., Tofler, O.B., Burvill, M.J., Reilly, K.A.: Alcohol consumption and gout. Med. J. Aust. 1, 1213 (1967)
Sandler, M., Baldock, E.: In vivo monamine oxidase activity in toxaemia of pregnancy. J. Obstet. Gynaec. 70, 279–283 (1963)
Sarre, H., Mertz, D.R.: Sekundäre Gicht bei Niereninsuffizienz. Klin. Wschr. 43, 1134–1140 (1965)
Schaffer, N.K., Dill, L.V., Cadden, J.F.: Urie acid clearance in normal pregnancy and preeclampsia. J. clin. Invest. 22, 201–206 (1943)
Schapiro, R.H., Scheig, R.L., Drummey, G.D., Mendelson, J.H., Isselbacher, K. J.: Effect of prolonged ethanol ingestion on the transport and metabolism of lipids in man. New Engl. J. Med. 272, 610–615 (1965)
Schlosstein, L., Kippen, I., Bluestone, R., Whitehouse, M.W., Klinenberg, J.R.: Association between hypouricemia and jaundice. Ann. rheum. Dis. 33, 308–312 (1974)
Schlosstein, L.H., Kippen, I., Whitehouse, M.W., Bluestone, R., Paulus, H.E., Klinenberg, J.R.: Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites. J. Lab. clin. Med. 82, 412–418 (1973)
Schneeweiss, J., Poole, G.W.: Hyperuricaemia due to pyrazinamide. Brit. med. J. 1960, II, 830 – 832
Schonfeld, G., Kudzma, D.J.: Type IV hyperlipoproteinemia: a critical appraisal. Arch. Intern. Med. 132, 55–62 (1973)
Scott, J.T., McCallum, F.M., Holloway, V.P.: Starvatin, ketosis and uric acid excretion. Clin. Sci. 27, 209–221 (1964)
Scott, J.T., Dixon, A. St. J., Bywaters, E.G.L.: Association of hyperuricaemia and gout with hyperparathyroidism. Brit. med. J. 1964, I, 1070–1073
Seegmiller, J.E., Grayzel, A.L., Laster, L., Liddle, L.: Uric acid production in gout. J. clin. Invest. 40, 1304–1314 (1961)
Seitchik, J., Szutka, A., Alper, C.: Further studies on the metabolism of N15-labelled uric acid in normal and toxemic pregnant women. Amer. J. Obstet. Gynec. 76, 1151–1155 (1958)
Semple, P.F., Carswell, W., Boyle, J.A.: Serial studies of the renal clearance of urate and inulin during pregnancy and after the Puerperium in normal women. Clin. Sci. molec. Med. 47, 559–565 (1974)
Shelp, W.P., Rieselbach, R.E.: Increased bidirectional urate transport per nephron following unilateral nephrectomy. Amer. Soc. Nephrol. Abst. 24 (1968)
Shelp, W.D., Steele, T.H., Rieselbach, R.E.: Comparison of urinary phosphate, urate and magnesium excretion following parathyroid hormone administration to normal man. Metabolism 18, 63–70 (1969)
Shulman, J.D., Lustberg, T.J., Seegmiller, J.E.: Hyperuricemia in branched chain ketoaciduria (maple syrup urine disease). Arthr. and. Rheum. 13, 347a (1970)
Simkin, P. A., Skeith, M.D., Healy, L.A.: Suppression of uric acid secretion in a patient with renal hypouricaemia. Advanc. exp. med. Biol. [B] 41, 723–728 (1974)
Simon, N.M., Smucker, J.E., O’Connor, V.J., Greco, F., del: Differential uric acid excretion in essential and renal hypertension. Circulation 39, 121–125 (1969)
Sirota, J.H., Yu, T.-F., Gutman, A.B.: Effect of benemid (p-[di-n-propyl-sulfamyl]benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J. clin. Invest. 31, 692–701 (1952)
Skeith, M.D., Healey, L. A., Cutler, R.E.: Urate excretion during mannitol and glucose diuresis. J. Lab. clin. Med. 70, 213–220 (1967)
Skeith, M.D., Healey, L. A., Cutler, R.E.: Effect of phloridzin on uric acid excretion in man. Amer. J. Physiol. 219, 1080–1082 (1970)
Sorensen, L.B., Benke, P.J.: Biochemical evidence for a distinct type of primary gout. Nature (Lond.) 213, 1122–1123 (1967)
Sorensen, L.B., Levinson, D.J.: Clinical evaluation of benzbromarone. A new uricosuric drug. Arthr. and Rheum. 19, 183–190 (1976)
Sougin-Mibashan, R., Horwitz, M.: The uricosuric action of ethyl biscoumacetate. Lancet 1955, I, 1191–1197
Sperling, O., Weinberger, A., Oliver, I., Liberman, U.A., Vries, A., de: Hypouricemia, hypercalci-uria and decreased bone density. A new hereditary syndrome. Advanc. exp. med. Biol. 41, 717–721 (1974)
Stamm, W.E., Webb, D.I. Partial deficiency of hepatic glucose-6-phosphatase in an adult patient. Arch. intern. Med. 135, 1107–1109 (1975)
Steele, T.H.: Evidence for altered renal urate reabsorption during changes in volume of the extracellular fluid. J. Lab. clin. Med. 74, 288–299 (1969)
Steele, T.H.: Urate secretion in man: The pyrazinamide suppression test. Ann. intern. Med. 79, 734–737 (1973)
Steele, T.H., Manuel, M.A., Boner, G.: Diuretics, urate excretion and sodium reabsorption: Effect of acetazolamide and urinary alkalinization. Nephron 14, 49–61 (1975)
Steele, T.H., Oppenheimer, S.: Factors affecting urate excretion following diuretic administration in man. Amer. J. Med. 47, 564–574 (1969)
Steele, T.H., Rieselbach, R.E.: The renal mechanism for urate homeostasis in normal man. Amer. J. Med. 43, 868–875 (1967a)
Steele, T.H., Rieselbach, R.E.: The contribution of residual nephrons within the chronically diseased kidney to urate homeostasis in man. Amer. J. Med. 43, 876–886 (1967b)
Stein, J.H., Ferris, T.F., Huprich, J.E., Smith, T.C., Osgood, R.W.: Effect of renal vasodilatation on the distribution of cortical blood flow in the kidney of the dog. J. clin. Invest. 50, 1429–1438 (1971)
Stein, H.B., Hasan, A., Fox, I.H.: Ascorbic acid-induced uricosuria. A consequence of megavi-tamin therapy. Ann. intern. Med. 84, 385–388 (1976)
Stormont, D., Davies, C., Emmerson, B.T.: Urate production in heterozygotes for glucose-6-phosphatase deficiency. Clin. chim. Acta 71, 303–308 (1976)
Suki, W.N., Hull, A.R., Rector, F.C., Seldin, D.W.: Mechanism of the effect of thiazide diuretics on calcium and uric acid. J. clin. Invest. 46, 1121 (1967)
Suki, W.N., Martinez-Maldonado, M., Rouse, D., Terry, A.: Effect of expansion of extracellular fluid volume on renal phosphate handling. J. clin. Invest. 48, 1888–1894 (1969)
Thompson, G.R., Mikkelsen, W.M., Willis III, P.W.: The uricosuric effect of certain oral anticoagulant drugs. Arthr. and Rheum. 2, 383–388 (1959)
Tran, M.H., Lellouch, J., Richard, J.L.: Fat body mass. II. Its relationships with some biological parameters, blood pressure and physical training in a population of 8660 men aged 20 to 55. Biomedicine 18, 499–506 (1973)
Trevaks, G., Lovell, R.R.H.: Effect of atromid and its components on uric acid excretion and on gout. Ann. rheum. Dis. 24, 572–575 (1965)
Verger, D., Leroux-Robert, C., Ganter, P., Richet, G.: Les tophus goutteux de la médullaire rénale des urémiques chroniques. Nephron 4, 356–370 (1967)
Weiner, I.M., Tinker, J.P.: Pharmacology of pyrazinamide; metabolic and renal function studies related to the mechanism of drug-induced urate retention. J. Pharmacol. exp. Ther. 180, 411 (1972)
Weinman, E.J., Eknoyan, G., Suki, W.N.: The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J. clin. Invest. 55, 283–291 (1975)
Weinstein, B., Irrevere, F., Watkin, D.M.: Lung carcinoma, hypouricemia and aminoaciduria. Amer. J. Med. 39, 520–526 (1965)
Whitehouse, F.W., Cleary, W.J.: Diabetes mellitus in patients with gout. J. Amer. med. Ass. 197, 73–76 (1966)
Wiedemann, E., Rose, H.B., Schwartz, E.: Plasma lipoproteins, glucose tolerance and insulin response in primary gout. Amer. J. Med. 53, 299–307 (1972)
Wiener, K.: Uraemia and hyperuricaemia in acute myocardial infarction. Clin. Chim. Acta 73, 45–50 (1976)
Wilson, D.M., Goldstein, N.P.: Renal urate excretion in patients with Wilson’s Disease. Kidney Int. 4, 331–336 (1973)
Woods, H.F., Alberti, K.G.M.M.: Dangers of intravenous fructose. Lancet 1972, II, 1354–1356
Woods, H.F., Eggleston, L.V., Krebs, H.A.: The cause of hepatic accumulation of fructose loading. Biochem. J. 119, 501–510 (1970)
Wyngaarden, J.B.: The effect of phenylbutazone on uric acid metabolism in two normal subjects. J. clin. Invest. 34, 256–262 (1955)
Yü, T.F., Berger, L., Gutman, A.B.: Hypoglycemic and uricosuric properties of acetohexamide and hydroxyhexamide. Metabolism 17, 309–316 (1968)
Yü, T.F., Berger, L., Stone, D.J., Wolf, J., Gutman, A.B.: Effects of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions. Proc. Soc. exp. Biol. 96, 264–267 (1957)
Yü, T.F., Gutman, A.B.: Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc. Soc. exp. Biol. (N.Y.) 90, 542 (1955)
Yü, T.F., Gutman, A.B.: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J. clin. Invest. 38, 1298 – 1315 (1959)
Yü, T.F., Kaung, C., Gutman, A.B.: Effect of glycine loading in plasma and urinary uric acid and amino acids in normal and gouty subjects. Amer. J. Med. 49, 352–359 (1970)
Yü, T.F., Sirota, J.H., Berger, L., Halpern, M., Gutman, A.B.: Effect of sodium lactate infusion on urate clearance in man. Proc. Soc. exp. Biol. (N.Y.) 96, 809–813 (1957)
Yü, T.F., Sirota, J.H., Gutman, A.B.: Effects of phenylbutazone on renal clearance of urate and other discrete renal functions in gouty subjects. J. clin. Invest. 32, 1121–1132 (1953)
Zimmer, J.G., Demis, D.J.: Associations between gout, psoriasis and sarcoidosis with consideration of their pathogenic significance. Ann. intern. Med. 64, 786–796 (1966)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Emmerson, B.T. (1978). Abnormal Urate Excretion Associated with Renal and Systemic Disorders, Drugs, and Toxins. In: Kelley, W.N., Weiner, I.M. (eds) Uric Acid. Handbook of Experimental Pharmacology, vol 51. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66867-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-66867-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66869-2
Online ISBN: 978-3-642-66867-8
eBook Packages: Springer Book Archive